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Abstract
Background: The host response to dengue virus infection is characterized by the production of numerous cytokines, but
the overall picture appears to be complex. It has been suggested that a balance may be involved between protective and
pathologic immune responses. This study aimed to define differential immune responses in association with clinical
outcomes by gene expression profiling of a selected panel of inflammatory genes in whole blood samples from children
with severe dengue infections.
Methodology/Principal Findings: Whole blood mRNA from 56 Indonesian children with severe dengue virus infections was
analyzed during early admission and at day 21, 0, 1, and 5–8 after defervescence. Levels were related to baseline levels
collected at a 1-month follow-up visit. Processing of mRNA was performed in a single reaction by multiplex ligation-
dependent probe amplification, measuring mRNA levels from genes encoding 36 inflammatory proteins and 14 Toll-like
receptor (TLR)-associated molecules. The inflammatory gene profiles showed up-regulation during infection of eight genes,
including IFNG and IL12A, which indicated an antiviral response. On the contrary, genes associated with the nuclear factor
(NF)-kB pathway were down-regulated, including NFKB1, NFKB2, TNFR1, IL1B, IL8, and TNFA. Many of these NF-kB pathway–
related genes, but not IFNG or IL12A, correlated with adverse clinical events such as development of pleural effusion and
hemorrhagic manifestations. The TLR profile showed that TLRs were differentially activated during severe dengue infections:
increased expression of TLR7 and TLR4R3 was found together with a decreased expression of TLR1, TLR2, TLR4R4, and TLR4
co-factor CD14.
Conclusions/Significance: These data show that different immunological pathways are differently expressed and associated
with different clinical outcomes in children with severe dengue infections.
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Introduction
Dengue disease is emerging in the developing world at an
alarming rate [1]. Moreover, the disease is potentially lethal, but
only supportive measures are available. A major obstacle in the
development of novel therapeutic strategies is that the pathophys-
iology of dengue disease is poorly understood [2,3]. Clinically,
dengue disease is a mosquito-borne disease especially affecting
children in endemic, mostly tropical regions and is caused by
infection with dengue virus, a member of the Flaviviridae family [4].
Though most patients only suffer from a mild febrile illness called
dengue fever (DF), a relatively small group of patients experiences
more severe forms of disease which are characterized by increased
vascular permeability leading to bleeding manifestations and
shock, such as dengue hemorrhagic fever (DHF) and dengue shock
syndrome (DSS) [5].
The mechanism leading to severe, critical disease is insuffi-
ciently understood. Antibody-dependent enhancement of viral
replication is generally thought to play a role since most cases of
DHF/DSS occur after secondary infection by a dengue virus
serotype different from the first infection [2,6–8]. Severe disease is
characterized by high viremia titers, coagulation abnormalities
and activation of the immune system [5,9]. The host defense
strongly depends on interferon (IFN)-c production, but other
cytokines are also involved, as well as antibody production and T
cell responses [10,11]. Typically, cytokine levels are highest among
the day of defervescence, which is defined as the first day after the
start of fever that the body temperature returns to normal. At the
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the risk of shock development is increased [12]. The relationship
between cytokine production and severe disease is not fully
understood, but it is increasingly recognized that a balance is
involved between protective and pathologic immune responses [2].
In general, cytokine production depends on the recognition of
pathogens via Toll-like receptors (TLRs). In viral disease, TLR3,
TLR7, TLR8 and TLR9 are commonly involved, but specific
knowledge about TLRs in dengue infections is limited [13–15].
RNA-based gene expression profiling methods offer the
opportunity to examine complex biological processes in a large
context. We previously developed and validated an RT-PCR
based assay for the measurement of multiple mRNA levels in a
single reaction, multiplex ligation-dependent probe amplification
(MLPA) [16–19]. The MLPA panel includes 36 target genes of
various mediators of inflammation, such as cytokines, chemokines
and intracellular signalling molecules and in addition a second
panel has been developed to measure 14 TLR associated genes
[20].
In order to investigate patterns of innate immune responses in
severe dengue infections in children at the level of gene
transcription, blood samples were collected from a group of
children with severe dengue disease in Indonesia. The samples
were analyzed using MLPA technology and associated with
clinical outcomes.
Materials and Methods
Study design
The study was designed as a prospective, observational cohort
study and was conducted in the Dr. Kariadi University Hospital in
Semarang, Indonesia, simultaneously with an other study
investigating the pathophysiology of hemorrhagic tendencies in
dengue virus infections [21]; from this cohort, only patients were
included for whom RNA was successfully isolated, which was
available for all patients consecutively admitted from February
2002 until March 2003. The ethics committee/ institutional
review board of the dr Kariadi University Hospital in Semarang,
Indonesia, approved all legal, ethical, clinical and laboratory
aspects of the study including the informed consent procedure,
which was obtained, after informing the patients and their parents
and/or guardians in local language, as a written form from
children’s parents or guardians before inclusion. Children, aged 3
to 14 years, admitted to the paediatric intensive care unit or a
‘high nursery care unit’ with a clinical diagnosis of suspected DHF
or DSS were included. Demographic and clinical data were
collected using a standardized data collection form. A Tourniquet
test was performed to detect a bleeding tendency together with
chest- and abdominal X-rays and ultrasonography to detect ascites
and/or pleural effusion. Children were classified as having DF,
DHF or DSS according to WHO criteria [1]. In brief, the clinical
diagnosis of DHF included the presence of fever, a hemorrhagic
tendency, thrombocytopenia (,100610
3/mm
3), evidence of
pleural effusion and/or a significant (.20%) rise, or drop after
volume replacement therapy, of hematocrit values. DSS was
defined as DHF with evidence of circulatory failure. All other cases
not meeting these criteria were diagnosed DF. Citrated blood
samples were obtained on the day of admission, days 1, 2 and 7
after admission and at a 1-month follow-up visit. Because in
dengue disease each patient experiences a different clinical course
and is hospitalized at different time points in that course, these
blood samples were referred to a common clinical time point,
which is the day of defervescence according to international
agreement. In addition, samples obtained at admission from
patients presenting .1 day before defervescence were clustered
into a time point designated ‘Early’, which indicates early immune
activation before defervescence.
Diagnostic procedures
Paired blood samples were tested for serologic evidence of acute
dengue infection. Dengue virus specific IgG and IgM antibodies
were measured by ELISA (Focus Technologies, Cypress, Ca,
USA). The sensitivity and specificity of these tests were evaluated
previously [22]. Cases were considered serologically-confirmed if
the IgM ELISA was positive during the acute phase of disease
(optical density of the sample higher than the optical density of the
cut-off serum provided by the manufacturer) and/or if a four-fold
increase in IgG titre was demonstrated in paired acute and
convalescent sera. For some patients, a definitive serodiagnosis was
not possible because no convalescent sample was obtained.
Dengue virus antigen and/or viral RNA was detected in these
cases using a dot blot immunoassay and/or a dengue serotype
specific reverse transcription PCR, respectively [23]. Patients with
definitive serodiagnosis and/or positive dot blot and/or positive
PCR were considered to have confirmed dengue virus infection.
mRNA analysis
Blood samples were centrifuged within 1–2 hours after retrieval
at 15uC for 20 minutes at 16006g. Subsequently, plasma was
separated and red blood cells were lysed using Red Blood Cell lysis
Buffer (Roche, Mannheim, Germany) according to the manufac-
turer’s protocol. Total white blood cells were stored at 280uCi n
mRNA lysis/-binding buffer (Roche) and transported to the
Netherlands on dry ice where total mRNA was isolated using High
Author Summary
Dengue virus infection is an impressively emerging disease
that can be fatal in severe cases. It is not precisely clear
why some patients progress to severe disease whereas
most patients only suffer from a mild infection. In severe
disease, a ‘‘cytokine storm’’ is induced, which indicates the
release of a great number of inflammatory mediators
(‘‘cytokines’’). Evidence suggested that a balance could be
involved between protective and pathologic cytokine
release patterns. We studied this concept in a cohort of
Indonesian children with severe dengue disease using a
gene expression profiling method.
The study showed that the immune response to severe
dengue infection was characterized by up-regulation of
interferon pathway–associated cytokines and down-regu-
lation of nuclear factor (NF)-kappaB pathway–associated
cytokines. Many of the NF-kappaB pathway–related genes,
but not the interferon pathway–associated genes, corre-
lated with adverse clinical events such as development of
pleural effusion and hemorrhagic manifestations. In
addition, the study showed that the expression of specific
pathogen recognition receptors called Toll-like receptors
was differentially regulated in patients with dengue.
Together, the data show that different immunological
pathways may indeed be differently expressed and
associated with different clinical outcomes in children
with severe dengue infections.
mRNA Profiling in Dengue Infection
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inflammatory molecules was analyzed by MLPA as described
previously [16]. In addition a second panel was added measuring
the involvement of multiple TLR related genes [20]. MLPA is
insensitive to the total amount of mRNA that is included in the
reaction; therefore, the profile is independent of the total white
blood cell (WBC) count. All samples were tested with the same
batches of reagents, and a negative and endotoxin-stimulated
control sample were included on each plate. The final polymerase
chain reaction (PCR) fragments amplified with carboxyfluores-
cein-labeled primers were separated by capillary electrophoresis
on a 16-capillary ABI-Prism 3100 Genetic Analyzer (Applied
Biosystems, Nieuwerkerk aan de IJssel, The Netherlands). Peak
area and height were processed using GeneScan analysis software
(Applied Biosystems). The levels of mRNA for each gene were
expressed as a normalized ratio of the peak area divided by the
peak area of a control gene, beta 2 microglobulin (B2M), resulting
in the relative abundance of mRNAs of the genes of interest.
Statistical analysis
All calculations were carried out using SPSS version 13.0 (SPSS
Inc., Chicago, IL, USA). The relative mRNA levels of subjects
from time-point ‘Early’ and day 21, 0, 1 and 5–8 post
defervescence were compared to baseline levels collected at a 1-
month follow up visit using Wilcoxon signed ranks test. mRNA’s
with .80% of values below the detection limit were excluded from
analysis and considered not detectable. P-values for each time
point were corrected for multiple comparisons according to the
method of Benjamini and Hochman, with q=0.1 [24]. Associa-
tions with clinical variables were calculated by univariate logistic
regression analysis and odds ratios6SE are presented. A P,0.05
was considered statistically significant.
Results
Patient characteristics
Samples for mRNA analysis were collected from 56 children
with confirmed dengue virus infections. All children presented
with clinically severe disease; the patients were classified according
to WHO criteria [1] as having DF (n=7; 13%), DHF (n=29;
51%) or DSS (n=20; 36%). Twenty patients presented more than
1 day before defervescence (median 3 days before defervescence;
interquartile range 2–3). These patients had experienced symp-
toms since 4 days before defervescence (median; interquartile
range 3–5). Further patient characteristics at admission are given
in Table 1. During stay at the hospital, 10 patients (18%)
developed one or more complications related to their dengue
infections. Profound shock was noted in 7 children (13%) and
recurrent shock in 5 children (9%). Other complications included
disseminated intravascular coagulation (n=3; 5%), encephalopa-
thy (n=3; 5%) or pulmonary edema (n=1; 2%). Eventually, 4
patients (7%) died despite treatment. These patients had all been
classified as having DSS; two of them died from profound shock;
one patient also had recurrent shock and encephalopathy and one
patient suffered in addition from disseminated intravascular
coagulation. The surviving patients all made a complete recovery
within a maximum of 12 days of stay in the hospital.
Inflammatory gene expression profiling
Gene expression profiles of 36 inflammatory genes during
hospital stay of each fever day were compared to baseline values at
a 1-month follow up visit (Table 2). The profile showed up-
regulation of 8 genes, down-regulation of 7 genes and no effect on
13 genes, whereas 8 genes were not detectable. Most gene
Table 1. Clinical characteristics of 56 children from Indonesia admitted to the hospital with severe dengue virus infections.
All (n=56) DF/DHF
a) (n=36) DSS
a) (n=20)
Age, median (IQR), years 6 (5–9) 7 (5–10) 6 (5–7)
Male sex, n (%) 22 (39) 14 (39) 8 (40)
Primary infection
b), n (%) 4 (7) 4 (11) 0 (0)
Duration of symptoms before admission, median (IQR), days 4 (3–4) 3 (3–4) 4 (3–5)
Positive Tourniquet test, n (%) 33 (59) 27 (75) 6 (30)
Petechiae, ecchymoses or purpura, n (%) 28 (50) 18 (50) 10 (50)
Mild spontaneous bleeding, n (%) 15 (27) 9 (25) 6 (30)
Severe bleeding (hematemesis and/or melena), n (%) 5 (9) 2 (6) 3 (15)
Thrombocytopenia (platelet count ,100 10
3/mm
3), n (%) 52 (93) 32 (89) 20 (100)
Hematocrit .20% above normal for age, n (%) 11 (20) 7 (19) 4 (20)
Hematocrit .20% drop after volume replacement, n (%) 16 (29) 10 (28) 6 (30)
Pleural effusion, n (%) 44 (79) 26 (72) 18 (90)
Ascites, n (%) 19 (34) 11 (31) 8 (40)
Hypoproteinaemia (,6.0 g/L), n (%) 25 (45) 16 (44) 9 (45)
Hypotension for age, n (%) 15 (27) 6 (17) 9 (45)
Pulse pressure #20 mmHg, n (%) 24 (43) 10 (28) 14 (70)
Heart frequency, median (IQR), min
21 120 (112–132) 120 (110–131) 122 (120–132)
Duration of hospital stay, median (IQR), days 5 (3–6) 4 (3–5) 6 (3–7)
Mortality, n (%) 4 (7) 0 (0) 4 (20)
a)dengue fever (DF), dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS) according to WHO criteria
b)primary or secondary infection
doi:10.1371/journal.pntd.0000215.t001
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(day 0). The expression patterns revealed up-regulation of the Th1
type cytokines interferon-c (IFNG) and interleukin-12a (IL12A)o n
consecutive days, indicating an antiviral response. Another gene
strongly induced by dengue infection was MIF, a marker of
macrophage activation. No other cytokine genes from the MLPA
panel were up-regulated, but some other genes were involved,
including cell cycle control genes such as cyclin-dependent kinase
inhibitor 1A (CDKN1A) at consecutive days and polyadenylate-
specific ribonuclease (PARN) and protein-tyrosine phophatase
nonreceptor-type 1 (PTPN1) at day 0 only. Furthermore,
glutathione S-transferase (GSTP1), involved in detoxification
metabolism, was significantly up-regulated at day 21 and day 1
and MD2, a co-factor of TLR4, was activated early before
defervescence. Of note, in contrast to the enhanced levels of
antiviral cytokine mRNAs, down-regulation of genes was observed
at consecutive days for a whole cluster of genes associated with the
nuclear factor (NF)-kB pathway (Figure 1). Transcription levels of
NF-kB subunit 2 (NFKB2) and tumor necrosis factor receptor 1
(TNFR1) were decreased as well as levels of the cytokine genes
IL1B at day 21 and IL8, TNFA and NF-kB subunit 1 (NFKB1)a t
day 0. Furthermore, transcription was inhibited during the early
phase of PTPN4A2.
TLR gene expression profiling
The gene expression profiles of 14 TLR associated genes during
admission showed up-regulation of 2 genes, down-regulation of 4
genes and no effect on 6 genes, whereas 2 genes were not
detectable (Table 3). Most gene expression profile changes
occurred at day 21 and day 0. Up-regulation of TLR gene
transcription was observed for TLR7 and TLR4 transcript variant
3( TLR4R3) during the early phase and at day 21; in addition,
TLR7 was up-regulated at day 0 and TLR4R3 at day 1. Decreased
expression of TLRs was noted for TLR1, TLR4R4 and TLR4 co-
factor CD14 at day 21 and day 0, whereas decreased expression of
TLR4R4 was also noted during early activation and for TLR2 at all
time-points. No detectable levels were measured of the viral
recognition associated TLR genes TLR3 and TLR9.
Figure 1. Differential gene expression patterns in dengue disease. mRNA levels (arbitrary units relative to b-2-microglobulin expression;
presented as mean6SEM) from Indonesian children (n=56) with severe dengue infections from day ‘Early’ (including admission samples of patients
presenting .1 day before defervescence; n=20), 21, 0, 1 and 5–8 from defervescence. Whereas IFNG and IL12A were up-regulated, a cluster of genes
related to the NF-kB pathway was down-regulated, including NFKB1, NFKB2, IL1B and IL8.
doi:10.1371/journal.pntd.0000215.g001
mRNA Profiling in Dengue Infection
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Clinical associations of gene expression levels with parameters of
disease severity were calculated at day 21, 0 and 1 from
defervescence. Odds ratios and p-values are presented in Table 4.
The development of DSS correlated significantly with down-
regulation of IL4R2. Pleural effusion as diagnosed by either chest
X-ray or ultrasonography was associated with up-regulation of
members of the NF-kB pathway such as TNFA and TNFR1, but
also with IL1RA, MIP1A and TLR1 and was inversely related to
MIF and TLR7. Hemorrhagic manifestations including mild and/
or severe bleeding were associated with the NF-kB pathway
members NFKB1 and TNFR1. The occurrence of severe
complications such as profound or recurrent shock, disseminated
intravascular coagulation, encephalopathy and/or pulmonary
Table 2. Inflammatory gene expression profiling of 56 children from Indonesia with severe dengue virus infections: P-values
indicating up- or down-regulation relative to baseline.
Gene transcription
response
Gene
symbol Descriptive name P-value
b)
Day
a) E Day
a) -1 Day
a) 0 Day
a) 1 Day
a) 5–8
Up CDKN1A Cyclin-dependent kinase inhibitor, 1A 0.008 0.033 0.002 0.013 0.017
GSTP1 Glutathione S-transferase NS 0.016 NS 0.008 NS
IFNG Interferon, gamma NS 0.009 0.002 0.043 0.015
IL12A Interleukin 12, subunit p35 NS NS 0.002 0.005 NS
MD2 MD2 protein 0.011 NS NS NS NS
MIF Macrophage migration inhibitory factor 0.041 0.000 0.002 0.000 0.018
PARN Polyadenylate-specific ribonuclease NS NS 0.016 NS NS
PTPN1 Protein-tyrosine phophatase, nonreceptor-type 1 NS NS 0.021 NS NS
Down IL1B Interleukin 1, beta 0.029 0.016 NS NS NS
IL8 Interleukin 8 0.010 NS 0.004 NS NS
NFKB1 Nuclear factor kappa-B, subunit 1 NS NS 0.043 NS NS
NFKB2 Nuclear factor kappa-B, subunit 2 0.002 0.002 0.005 0.001 NS
PTP4A2 Protein-tyrosine phophatase, type 4a, 2 0.007 NS NS NS NS
TNFA Tumor necrosis factor, alpha NS NS 0.016 NS NS
TNFR1 Tumor necrosis factor receptor superfamily 1a 0.002 0.001 0.002 0.011 NS
Non significant BMI1 BMI-1 oncogene homolog NS NS NS NS NS
IL1RA Interleukin 1 receptor antagonist NS NS NS NS NS
IL4 Interleukin 4 NS NS NS NS NS
IL15R1 Interleukin 15, transcript variants 1 and 3 NS NS NS NS NS
LTA Lymphotoxin alfa NS NS NS NS NS
MCP1 Monocyte chemotactic protein 1 NS NS NS NS NS
MIP1A Macrophage inflammatory protein 1, alpha NS NS NS NS NS
MIP1B Macrophage inflammatory protein 1, beta NS NS NS NS NS
MYC Oncogene MYC NS NS NS NS NS
NFKB1A Nuclear factor kappa-B inhibitor alpha NS NS NS NS NS
PDE4B Phosphodiesterase 4B, cAMP specific NS NS NS NS NS
SERPB9 Serine proteinase inhibitor, clade B, member 9 NS NS NS NS NS
THBS1 Thrombospondin 1 NS NS NS NS NS
Not detectable IL1A Interleukin 1, alpha ND ND ND ND ND
IL2 Interleukin 2 ND ND ND ND ND
IL6 Interleukin 6 ND ND ND ND ND
IL10 Interleukin 10 ND ND ND ND ND
IL18 Interleukin 18 ND ND ND ND ND
MCP2 Monocyte chemotactic protein 2 ND ND ND ND ND
PDGFB Platelet-derived growth factor beta ND ND ND ND ND
TF Tissue factor ND ND ND ND ND
a)day E, 21, 0, 1 and 5–8 post defervescence; defined as the first day after start of fever that the body temperature returns to normal. E=Early; defined as clustering of
admission samples of patients presenting .1 day before defervescence (n=20).
b)P-values indicate up- or down-regulation of gene transcription during infection, relative to baseline levels collected from a 1-month follow-up visit. A P-value,0.05
was considered statistically significant. NS=Not Significant. ND=Not Detectable.
doi:10.1371/journal.pntd.0000215.t002
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but CD14, IL1B, IL1RA, NFKB1, PDE4B, TLR1 and TLR10
showed a trend towards significance, particularly during deferves-
cence.
Discussion
The pathogenesis of severe critical disease following dengue
virus infection involves the activation of multiple inflammatory
pathways. This is the first study to report high throughput gene
expression profile changes of inflammatory genes in children with
severe dengue virus infections. The study revealed two points of
interest. First, the profile showed characteristics of a general
antiviral response with up-regulation of IFNG, which is an
established major antiviral cytokine in dengue disease, together
with up-regulation of IL12A, a potent stimulator of IFN-c
production [11,25]. In contrast, no other cytokine genes from
the panel were up-regulated, but a cluster of genes related to the
NF-kB pathway was down-regulated, including NFKB1, NFKB2,
TNFR1, IL1B, IL8 and TNFA. In addition, the NF-kB pathway
linked expression patterns of NFKB1, TNFR1 and TNFA
correlated with adverse clinical events, such as the development
of pleural effusion and hemorrhagic manifestations. A second
finding of interest in this study is that this is the first report of in vivo
differential activation of multiple TLRs in dengue disease, which
may implicate a role for these receptors in dengue infections.
The intracellular NF-kB pathway is a major route for
inflammatory stimuli to the release of most pro-inflammatory
mediators, including TNF-a, IL-1ß and IL-8 [26]. Most of these
mediators were reported to be elevated in plasma from patients
with severe dengue disease, especially around the day of
defervescence [27,28]. In contrast, studies showed poor NF-kB
related cytokine production after stimulation of peripheral blood
mononuclear cells which were isolated from patients with dengue
[29–31]. Also in the current study most in vivo NF-kB pathway
associated gene transcription levels were down-regulated. These
results may be limited to the site of production, i.e. located to
circulating leucocytes, because in vitro data showed that dengue
virus was able to stimulate the NF-kB pathway in other, non
leukocyte cells, such as human hepatoma cells and endothelial cells
[32,33]. Yet, no studies have directly compared different cell types
or investigated the mechanism or function of NF-kB down-
regulation by dengue. Down-regulation of inflammatory genes
during the day of defervescence may also be the result of time
effects such as depletion- or negative feed-back mechanisms
following previous activation of these genes. Time effects play an
important role in dengue disease; the immune response can be
roughly divided into early inflammatory changes, changes during
defervescence and late changes after defervescence [12,34]. An
exploration of ‘early’ time effects was carried out in our study by
clustering all early admission samples from patients entering the
hospital more than one day before defervescence. However,
because no major differences were noted in comparison to changes
observed during defervescence, it shows no evidence that early
time effects affecting the investigated genes interfered with later
changes during defervescence.
The production of cytokines such as INF-c indicates activation
of an appropriate, protective immune response to dengue virus
infection. However, overwhelming production of cytokines and/or
cross-activation of pathological immune responses has been
postulated as a mechanism to endothelial damage and subsequent
vascular leakage, shock and death. Previous studies showed direct
associations between mortality and increased protein plasma levels
of IL-6, IL-8, IL-10, IL-1RA and MIF [31,35,36]. In addition,
increased plasma levels of TNF-a, TNFR1, TNFR2, IL2R, IL-8,
IL-13, IL-18, soluble CD8 and TGFß1 protein plasma levels were
associated with development of DSS, whereas levels of TNF-a also
correlated with hemorrhagic manifestations and levels of TNFR1
Table 3. TLR gene expression profiling of 56 children from Indonesia with severe dengue virus infections: P-values indicating up-
or down-regulation relative to baseline.
Gene transcription
response
Gene
symbol Descriptive name P-value
b)
Day
a) E Day
a) 21 Day
a) 0 Day
a) 1 Day
a) 5–8
Up TLR4R3 Toll-like receptor 4, transcript variant 3 0.003 0.000 NS 0.030 NS
TLR7 Toll-like receptor 7 0.001 0.017 0.013 NS NS
Down CD14 Monocyte differentiation antigen CD14 NS 0.002 0.044 NS NS
TLR1 Toll-like receptor 1 NS 0.035 0.002 NS NS
TLR2 Toll-like receptor 2 0.026 0.009 0.005 0.048 0.043
TLR4R4 Toll-like receptor 4, transcript variant 4 0.005 0.030 0.010 NS NS
Non significant TLR4R1 Toll-like receptor 4, transcript variant 1 NS NS NS NS NS
TLR4R2 Toll-like receptor 4, transcript variant 2 NS NS NS NS NS
TLR5 Toll-like receptor 5 NS NS NS NS NS
TLR8R1 Toll-like receptor 8, transcript variant 1 NS NS NS NS NS
TLR8R2 Toll-like receptor 8, transcript variant 2 NS NS NS NS NS
TLR10 Toll-like receptor 10 NS NS NS NS NS
Not detectable TLR3 Toll-like receptor 3 ND ND ND ND ND
TLR9 Toll-like receptor 9 ND ND ND ND ND
a)day E, 21, 0, 1 and 5–8 post defervescence; defined as the first day after start of fever that the body temperature returns to normal. E=Early; defined as clustering of
admission samples of patients presenting .1 day before defervescence (n=20).
b)P-values indicate up- or down-regulation of gene transcription during infection, relative to baseline levels collected from a 1-month follow-up visit. A P-value,0.05
was considered statistically significant. NS=Not Significant. ND=Not Detectable.
doi:10.1371/journal.pntd.0000215.t003
mRNA Profiling in Dengue Infection
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context, it is important to define which immune responses are
protective and which responses play a mere pathological role.
Clustering of the confusingly large amount of mediators which
appear to be involved in dengue into collective pathways can help
to retrieve a clearer picture, if possible. A previous microarray
based study revealed this way that activation of interferon-I
dependent pathways was associated with beneficial outcomes in
adult patients with dengue [41]. The current study did not
investigate interferon-I dependent pathways, but included the
genes IFNG and IL12A and found no evidence of an association of
these genes with adverse outcomes. In contrast, the current study
found associations of various other inflammatory genes with
adverse outcomes and it showed that at least for some part these
associations could be clustered to members of the NF-kB pathway:
TNFA and TNFR1 were highly associated with pleural effusion
(odds ratios 118.3659.6 and 31.4615.9, respectively) and NFKB1
and TNFR1 correlated with hemorrhagic manifestations (odds
ratios 14.066.4 and 14.066.9, respectively). In addition, a trend
towards significance was found for association of the NF-kB
pathway related genes IL1B and NFKB1 with the occurrence of
severe complications and for IL8 and NFKB2 with pleural effusion.
Of note, TNF-a is one of the major NF-kB pathway effector
molecules and others showed that in two independent mouse
models of dengue infection, antibodies to TNF-a significantly
decreased dengue disease severity and mortality in vivo [42,43].
Also, it was demonstrated that addition of serum from patients
with acute dengue infection to endothelial cells in vitro induced
increased expression of the endothelial cell activation marker
ICAM-1 and that this effect could be blocked by antibodies to
TNF-a [44]. Based upon these data all together, activation of
TNF-a in particular, but possibly of the NF-kB pathway as a
whole, may be involved in the mechanism of vascular leakage and
transition into severe disease in patients with dengue.
Pathogen recognition is an important step in the activation of
inflammatory pathways and TLRs play a major role in this process
[26]. Each TLR is associated with specific ligands and response
patterns, though interactions occur and in fact each pathogen is
recognized by not only one TLR but by a set of TLRs, usually
together with also other pattern-recognition receptors [45]. In the
current study, the in vivo role of ten TLRs during dengue infection
was explored and differential gene expression of TLRs was found:
Table 4. Association of inflammatory gene expression levels with disease severity parameters in 56 children from Indonesia with
severe dengue virus infections during defervescence.
Parameter Day
a) 21 Day
a) 0 Day
a) 1
Marker OR
b) SE
b) P
b) OR
b) SE
b) P
b) OR
b) SE
b) P
b)
DSS IL4R2 27.22 5.26 0.001* NS NS NS NS NS NS
PTPN1 NS NS NS NS NS NS 37.7 20.6 0.067
Complications CD14 NS NS NS 0.624 0.375 0.097 NS NS NS
IL1B NS NS NS 23.0 13.9 0.099 NS NS NS
IL1RA NS NS NS 11.8 7.00 0.091 NS NS NS
NFKB1 NS NS NS 35.4 21.4 0.098 NS NS NS
PDE4B NS NS NS NS NS NS 6.19 3.32 0.063
TLR1 NS NS NS 2.16 1.12 0.053 NS NS NS
TLR10 NS NS NS 16.5 9.78 0.092 NS NS NS
Pleural effusion CD14 NS NS NS 0.878 0.504 0.082 0.848 0.476 0.075
IL1RA NS NS NS 21.6 9.89 0.029* 9.75 5.82 0.094
IL4R2 NS NS NS 38.6 22.7 0.09 NS NS NS
IL8 NS NS NS 11.4 60.1 0.061 NS NS NS
MIF NS NS NS 210.9 5.39 0.043* 213.0 5.47 0.017*
MIP1A NS NS NS NS NS NS 217.1 104 0.037*
NFKB2 NS NS NS 64.4 36.2 0.075 NS NS NS
TLR1 2.13 1.07 0.046* NS NS NS NS NS NS
TLR4R4 6.59 3.29 0.045* 13.7 6.95 0.049* 10.6 6.04 0.077
TLR7 24.05 1.98 0.041* 25.24 2.55 0.038* NS NS NS
TNFA NS NS NS 118.3 59.6 0.047* NS NS NS
TNFR1 13.4 7.53 0.075 31.4 15.9 0.048* 12.5 6.81 0.067
Hemorrhagic manifestations IL4R2 NS NS NS NS NS NS 7.18 4.31 0.095
NFKB1 NS NS NS NS NS NS 14.0 6.42 0.029*
PTP4A2 NS NS NS NS NS NS 5.03 2.77 0.07
TLR5 11.0 6.33 0.083 NS NS NS NS NS NS
TNFR1 NS NS NS NS NS NS 14.0 6.86 0.041*
a)Day 21, 0 and 1 post defervescence; defined as the first day after start of fever that the body temperature returns to normal.
b)OR6SE=odds ratio6standard error. A P-value ,0.05 was considered statistically significant (
*). P-values showing a trend to significance (,.10) are also shown.
NS=Not Significant.
doi:10.1371/journal.pntd.0000215.t004
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decreased expression of TLR1, TLR2, TLR4R4 and TLR4 co-
factor CD14. These results show that the transcription profile of
the total white blood cells is perturbed in children with severe
dengue disease; the lack of clustered data hampers further
interpretation of these results. The in vivo role of TLR7 in
particular though, which was up-regulated in our panel and
associated with a lack of pleural effusion in patients during fever
day -1 and day 0 (odds ratios 4.0561.98 and 5.2462.55,
respectively) may be of interest to be further explored, also
because previous investigators identified TLR7 as an endosomal
pattern-recognition receptor for single-stranded RNA viruses
including influenza virus and vesicular stomatitis virus [14,46]
and a recent study showed that TLR7 could be triggered by
dengue virus in vitro [47].
Gene profiling methods offer opportunities to examine
biological processes in great detail. Yet, due to the amount of
data and because mRNA levels may be subject to posttranslational
processing there is risk of over interpretation of results. Moreover,
because the current study is an observational study, it has difficulty
to distinguish between primary and secondary effects [48]. Still,
the current MLPA panel was validated before and proved useful
for the study of molecular mechanisms during various inflamma-
tory conditions [16–20]. The statistical error in the present study
was reduced as much as possible by applying Benjamini-Hochman
statistical correction for multiple testing [24]. Furthermore, the
error was reduced by testing at several days independently from
each other: still, most gene expression changes occurred at several
days consecutively. In addition, most changes were noted at the
day of defervescence with a more or less gradual decline of
changes during recovery; this pattern closely resembles data from
others [27,34]. As such, the data suggest that the observed effects
indeed represent effects related to the dengue infection.
The children included in our study were all clinically severely ill;
only these patients were included because gene array profiling
studies investigating intra-individual gene transcription changes,
such as differential activation of differential immunological
pathways, are best performed in extreme cases. Not all children
in our study could be identified as severe cases by WHO criteria: 7
patients (13%) were diagnosed as having DF. The limitations of
the WHO criteria to identify all patients suffering from clinically
severe disease have been observed before [49,50]; to circumvent
this problem, clinical associations were calculated not only for
fulfilment of DSS criteria, but also for other disease severity
parameters such as occurrence of complications, pleural effusion
and hemorrhagic manifestations. No associations were calculated
for mortality because of the low incidence (n=4; 7%).
With the limitations of an observational, gene array profiling
study in mind, the data from our study provide a first insight into
the molecular basis of inflammatory gene expression patterns in
peripheral blood leukocytes from children with severe dengue
infections in vivo. The profile showed up-regulation of the antiviral
cytokines IFNG and IL12A and down-regulation of the NF-kB
pathway. The function of these differential gene expression
patterns is not precisely clear, but may be related to multiple
associations between the NF-kB pathway and adverse clinical
outcomes. In addition to these data, it was found that the
expression of several TLRs was affected during severe dengue
disease.
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